Frozen out: freezing therapy saves sight in rare eye tumor study
NCT ID NCT04458935
First seen Feb 05, 2026 · Last updated May 10, 2026 · Updated 14 times
Summary
This study looks back at 20 years of medical records from 25 people who had a rare eye tumor called retinal hemangioblastoma treated with freezing therapy (cryotherapy). The goal is to see how well the treatment controls the tumor and prevents vision loss. No new participants are needed; researchers will analyze existing data from past patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON HIPPEL LINDAU DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Eye Institute (NEI)
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.